Advertisement

Picture EBD Group BioPharm America 2018 Boston Speakers 600x60px
Document › Details

Oxford Nanopore Technologies Ltd.. (5/9/18). "Press Release: Oxford Nanopore Announces Favourable Outcome in UK and German Patent Litigation against Pacific Biosciences".

Region Region United Kingdom (GB)
Organisations Organisation Oxford Nanopore Technologies Ltd.
  Group Oxford Nanopore (Group)
  Organisation 2 Pacific Biosciences of California Inc. (PacBio) (Nasdaq: PACB)
Products Product DNA sequencing technology
  Product 2 reagents (bio/biochemical)
Person Person Sanghera, Gordon (Oxford NanoLabs 200506 CEO)
     


Oxford Nanopore and Pacific Biosciences have agreed to discontinue UK and German litigation. In the settlement, Oxford Nanopore agreed not to sell its 2D kits in UK and Germany. 2D is, in any case, obsolete and was globally discontinued in May 2017, when Oxford Nanopore replaced it with the superior 1D^2 method.

Oxford Nanopore will continue to sell 1D^2 and other kits.

Gordon Sanghera, CEO of Oxford Nanopore, said: “We do not infringe their patents and the settlement has no impact on our current business or on our future plans. It is reassuring that PacBio has not succeeded in its strategy to try to prevent us from selling our real-time, scalable, ultra-long read, direct sequencing technology. In the meantime, we’re busy innovating and our technology continues to improve rapidly. Tune in, in two weeks, when 600 people will gather for London Calling. The conference will feature talks from 80 researchers at the forefront of nanopore sequencing in microbiology, cancer research, plant genetics, human genetics, environmental analysis, food & water surveillance, and healthcare/diagnostics, across our technology range including MinION, GridION and PromethION."

Nanopore devices perform DNA/RNA sequencing directly and in real time.

The technology is scalable from miniature devices to high-throughput installations.


   
Record changed: 2018-05-16

Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px

More documents for Oxford Nanopore (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2018 Boston Partnering 560x80px




» top